EKF Diagnostics and Stanbio to Exhibit IVD Portfolio at AACC

EKF Diagnostics and Stanbio, two leading global IVD businesses will be sharing the stage for the first time at the American Association for Clinical Chemistry’s Annual Meeting and Clinical Lab Expo (AACC 2012). EKF Diagnostics, and AACC regulars Stanbio Laboratory (Boerne, Texas), will be exhibiting the EKF Diagnostics Group’s range of IVD products, which has expanded since Stanbio became part of EKF Diagnostics in June 2011.

At booth #1631, EKF Diagnostics will be premiering to the US market the Quo-Test and Quo-Lab glycated hemoglobin (HbA1c) analyzers for near-patient measurement and monitoring of diabetes. Quo-Test, EKF Diagnostics’s flagship analyzer, is accurate, simple to use and delivers results in less than four minutes, making it ideal for the physician’s office. These industry-leading qualities have ensured that more than 1,000 units are already in use globally. Quo-Lab is specifically designed for developing markets, and uses the same methodology as Quo-Test within an even more compact casing. The four-step testing procedure makes it a very cost effective option for small laboratories and diabetes clinics.

Stanbio Laboratory will focus on the Stanbio Beta-Hydroxybutyrate LiquiColor^® (ß-HB) Reagent System, which quantitatively measures the main ketone produced during ketosis. As it provides quantitative results, unlike traditional testing methods, ß-HB is changing the way hospitals manage patients displaying symptoms of diabetic ketoacidosis. The liquid-stable reagent can be used on open channel analyzers from almost twenty different manufacturers.

To highlight the use of the Beta-Hydroxybutyrate LiquiColor^® Reagent System, Stanbio Laboratory and EKF Diagnostics are hosting a symposium entitled, “The value, efficacy and efficiency of Beta-Hydroxybutyrate”. This will be presented by renowned point-of-care expert, Dr James Nichols, Professor of Pathology at Tufts University School of Medicine, Boston, and Medical Director of Clinical Chemistry for Baystate Health in Springfield, Massachusetts. Dr Nichols will discuss the relative merits of the various methods of testing for diabetic ketoacidosis, including ß-HB. The free symposium will take place at 11.30 am on Wednesday July 18th at the Westin Bonaventure Hotel, Los Angeles (15 minutes’ walk from the LA Convention Centre). Early reservation is recommended as seating is limited.

For more information from EKF Diagnostics, please follow the company website link below, or click on the ‘request information’ tab. For more information on Stanbio, please visit the company's website.

You can visit EKF Diagnostics and Stanbio at the AACC 2012 Clinical Lab Expo, July 17-19, at the Los Angeles Convention Center in Los Angeles, CA - booth #1631.